Increased susceptibility to ATP via alteration of P2X receptor function in dystrophic mdx mouse muscle cells

FASEB Journal

Volumn 20, Issue 6, 2006, Pages 610-620

  Yeung, Davy ^a,d   Zabłocki, Krzysztof ^b   Lien, Chun Fu ^a   Jiang, Taiwen ^a   Arkle, Stephen ^a   Brutkowski, Wojciech ^b   Brown, James ^a   Lochmuller, Hanns ^f   Simon, Joseph ^c   Barnard, Eric A ^c   Górecki, Dariusz C ^a,e  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e Institute of Biomedical and Biomolecular Sciences   (United Kingdom)

^f NONE

Author keywords

ATP; Duchenne muscular dystrophy; mdx mouse; Myoblast; P2X receptor

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; DYSTROPHIN; MESSENGER RNA; PURINE P2X RECEPTOR; PURINE P2X4 RECEPTOR; PURINE P2X7 RECEPTOR; UTROPHIN; PURINE P2 RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MUSCLE CELL; MUSCULAR DYSTROPHY; MYOBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKELETAL MUSCLE; ANIMAL; C57BL MOUSE; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CELL LINE; DYSTROPHIN; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; RECEPTORS, PURINERGIC P2; RNA, MESSENGER; UTROPHIN;

EID: 33646239159     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-4022com     Document Type: Article

References (64)

1. Dalkilic, I., and Kunkel, L. M. (2003) Muscular dystrophies: genes to pathogenesis. Curr. Opin. Genet. Dev. 13, 231-238
2. Blake, D. J., Weir, A., Newey, S. E., and Davies, K. E. (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 82, 291-329
3. Chen, Y. W., Zhao, P., Borup, R., and Hoffman, E. P. (2000) Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J. Cell Biol. 151, 1321-1336
4. Porter, J. D., Khanna, S., Kaminski, H. J., Rao, J. S., Merriam, A. P., and Richmonds, C. R. (2002) A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum. Mol. Genet. 11, 263-272
5. Yeung, D., Kharidia, R., Brown, S. C., and Górecki, D. C. (2004) Enhanced expression of the P2X4 receptor in Duchenne muscular dystrophy correlates with macrophage invasion. Neurobiol. Dis. 15, 212-220
6. Lu, Z., and Smith, D. O. (1991) Adenosine 5′triphosphate increases acetylcholine channel open frequency in rat skeletal muscle. J. Physiol. (London) 436, 45-46
7. Henning, R. H. (1997) Purinoceptors in neuromuscular transmission. Pharmacol. Ther. 74, 115-128
8. North, R. A., and Barnard, E. A. (1997) Nucleotide receptors. Curr. Opin. Neurobiol. 7, 346-357
9. North, R. A. (2002) Molecular physiology of P2X receptors. Physiol. Rev. 82, 1013-1067
10. Tung, E. K. K., Choi, R. C. Y., Siow, N. L., Jiang, J. X. S., Karen, K. Y., Ling, K. K. Y., Simon, J., Barnard, E. A., and Tsim, K. W. K. (2004) P2Y2 receptor activation regulates the expression of acetylcholinesterase and acetylcholine receptor genes at vertebrate neuromuscular junctions. Mol. Pharmacol. 66, 794-806
11. Tsim, K. W., and Barnard, E. A. (2002) The signaling pathways mediated by P2Y nucleotide receptors in the formation and maintenance of the skeletal neuromuscular junction. Neurosignals 11, 58-64
12. Ryten, M., Yang, S. Y., Dunn, P. M., Goldspink, G., and Burnstock, G. (2004) Purinoceptor expression in regenerating skeletal muscle in the mdx mouse model of muscular dystrophy and in satellite cell cultures. FASEB J. 18, 1404-1406
13. Ryten, M., Hoebertz, A., and Burnstock, G. (2001) Sequential expression of three receptor subtypes for extracellular ATP in developing rat skeletal muscle. Dev. Dyn. 221, 331-341
14. Ryten, M., Dunn, P. M., Neary, J. T., and Burnstock, G. (2002) ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells. J. Cell Biol. 158, 345-355
15. Jiang, T., Yeung, D., Lien, C.-F., and Górecki, D. C. (2005) Localized expression of specific P2X receptors in dystrophin-deficient DMD and mdx muscle. Neuromuscul. Disord. 15, 225-236
16. Morgan, J. E., Beauchamp, J. R., Pagel, C. N., Peckham, M., Ataliotis, P., Jat, P. S., Noble, M. D., Farmer, K., and Partridge, T. A. (1994) Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Dev. Biol. 162, 486-498
17. Brun, C., Suter, D., Pauli, C., Dunant, P., Lochmuller, H., Burgunder, J. M., Schumperli, D., and Weis, J. (2003) U7 snRNAs induce correction of mutated dystrophin pre-mRNA by exon skipping. Cell. Mol. Life Sci. 60, 557-566
18. 2+ transients and currents in murine thymocytes: possible role for P2X receptors in death by neglect. Eur. J. Immunol. 29, 1635-1646
19. Ekokoski, E., Webb, T. E., Simon, J., and Tornquist, K. (2001) Mechanisms of P2 receptor-evoked DNA synthesis in thyroid FRTL-5 cells. J. Cell. Physiol. 187, 166-175
20. Koenig, M., Monaco, A. P., and Kunkel, L. M. (1988) The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53, 219-228
21. Love, D. R., Hill, D. F., Dickson, G., Spurr, N. K., Byth, B. C., Marsden, R. F., Walsh, F. S., Edwards, Y. H., and Davies, K. E. (1989) An autosomal transcript in skeletal muscle with homology to dystrophin. Nature (London) 4, 55-58
22. Lederfein, D., Yaffe, D., and Nudel, U. (1993) A housekeeping type promoter, located in the 3′ region of the Duchenne muscular dystrophy gene, controls the expression of Dp71, a major product of the gene. Hum. Mol. Genet. 2, 1883-1888
23. Bo, X., Jiang, L. H., Wilson, H. L., Kim, M., Burnstock, G., Surprenant, A., and North, R. A. (2003) Pharmacological and biophysical properties of the human P2X5 receptor. Mol. Pharmacol. 63, 1407-1416
24. De Man, J. G., De Winter, B. Y., Seerden, T. C., De Schepper, H. U., Herman, A. G., and Pelckmans, P. A. (2003) Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved. Br. J. Pharmacol. 140, 1108-1116
25. Chessell, I. P., Michel, A. D., and Humphrey, P. P. (1997) Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells. Br. J. Pharmacol. 121, 1429-1437
26. Jiang, L. H., Mackenzie, A. B., North, R. A., and Surprenant, A. (2000) Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol. Pharmacol. 58, 82-88
27. Humphreys, B. D., Virginio, C., Surprenant, A., Rice, J., and Dubyak, G. R. (1998) Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Mol. Pharmacol. 54, 22-32
28. Chakfe, Y., Seguin, R., Antel, J. P., Morissette, C., Malo, D., Henderson, D., and Seguela, P. (2002) ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels. J. Neurosci. 22, 3061-3069
29. Feng, Y. H., Wang, L., Wang, Q., Li, X., Zeng, R., and Gorodeski, G. I. (2005) ATP stimulates GRK-3 phosphorylation and beta-arrestin-2-dependent internalization of P2X7 receptor. Am. J. Physiol. 288, C1342-C1356
30. Solle, M., Labasi, J., Perregaux, D. G., Stam, E., Petrushova, N., Koller, B. H., Griffiths, R. J., and Gabel, C. A. (2001) Altered cytokine production in mice lacking P2X(7) receptors. J. Biol. Chem. 276, 125-132
31. Sandona, D., Danieli-Betto, D., Germinario, E., Biral, D., Martinello, T., Lioy, A., Tarricone, E., Gastaldello, S., and Betto, R. (2005) The T-tubule membrane ATP-operated P2X4 receptor influences contractility of skeletal muscle. FASEB J. 19, 1184-1186
32. Sim, J. A., Young, M. T., Sung, H. Y., North, R. A., and Surprenant, A. (2004) Reanalysis of P2X7 receptor expression in rodent brain. J. Neurosci. 24, 6307-6314
33. Sicinski, P., Geng, Y., Ryder-Cook, A. S., Barnard, E. A., Darlison, M. G., and Barnard, P. J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578-1580
34. Geng, Y., Sicinski, P., Górecki, D., and Barnard, P. J. (1991) Developmental and tissue-specific regulation of mouse dystrophin: the embryonic isoform in muscular dystrophy. Neuromuscul. Disord. 1, 125-133
35. Haggblad, J., and Heilbronn, E. (1988) P2-purinoceptor-stimulated phosphoinositide turnover in chick myotubes. FEBS Lett. 235, 133-136
36. Choi, R. C. Y., Siow, N. L., Cheng, A. W. M., Ling, K. K. Y., Tung, E. K. K., Simon, J., Barnard, E. A., and Tsim, K. W. K. (2003) ATP acts via P2Y1 receptors to stimulate acetylcholinesterase and acetylcholine receptor expression: transduction and transcription control. J. Neurosci. 23, 4445-4456
37. Araya, R., Riquelme, M. A., Brandan, E., and Saez, J. C. (2004) The formation of skeletal muscle myotubes requires functional membrane receptors activated by extracellular ATP. Brain Res. Rev. 47, 174-188
38. Cox, J. A., Barmina, O., and Voigt, M. M. (2001) Gene structure, chromosomal localization, cDNA cloning and expression of the mouse ATP-gated ionotropic receptor P2X5 subunit. Gene 270, 145-152
39. Collo, G., North, R. A., Kawashima, E., Merlo-Pich, E., Neidhart, S., Surprenant, A., and Buell, G. (1996) Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci. 16, 2495-2507
40. Torres, G. E., Egan, T. M., and Voigt, M. M. (1999) Heterooligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. J. Biol. Chem. 274, 6653-6659
41. Sperlagh, B., Illes, P., Gerevich, Z., and Kofalvi, A. (2001) Distinct mechanisms underlying alpha1-adrenoceptor and P2x purinoceptor operated ATP release and contraction in the guinea-pig vas deferens. Neurochem. Res. 26, 951-957
42. Atkinson, L., Batten, T. F., Moores, T. S., Varoqui, H., Erickson, J. D., and Deuchars, J. (2004) Differential co-localisation of the P2X7 receptor subunit with vesicular glutamate transporters VGLUT1 and VGLUT2 in rat CNS. Neuroscience 123, 761-768
43. Papp, L., Vizi, E. S., and Sperlagh, B. (2004) Lack of ATP-evoked GABA and glutamate release in the hippocampus of P2X7 receptor-/- mice. NeuroReport 15, 2387-2391
44. Virginio, C., Church, D., North, A. R., and Surprenant, A. (1997) Effect of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology 36, 1285-1294
45. Chessell, I. P., Simon, J., Hibell, A. D., Michel, A. D., Barnard, E. A., and Humphrey, P. P. (1998) Cloning and functional characterisation of the mouse P2X7 receptor. FEBS Lett. 439, 26-30
46. Hibell, A. D., Kidd, E. J., Chessell, I. P., Humphrey, P. P., and Michel, A. D. (2000) Apparent species differences in the kinetic properties of P2X(7) receptors. Br. J. Pharmacol. 130, 167-173
47. Bulfield, G., Siller, W. G., Wight, P. A., and Moore, K. J. (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA 81, 1189-1192
48. Adriouch, S., Dox, C., Welge, V., Seman, M., Koch-Nolte, F., and Haag, F. (2002) Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor. J. Immunol. 169, 4108-4112
49. Cseri, J., Szappanos, H., Szigeti, G. P., Csernatony, Z., Kovacs, L., and Csernoch, L. (2002) A purinergic signal transduction pathway in mammalian skeletal muscle cells in culture. Pfluegers Arch. 443, 731-738
50. Collet, C., Strube, C., Csernoch, L., Mallouk, N., Ojeda, C., Allard, B., and Jacquemond, V. (2002) Effects of extracellular ATP on freshly isolated mouse skeletal muscle cells during pre-natal and post-natal development. Pfluegers Arch. 443, 771-778
51. Sneddon, P., Westfall, T. D., Todorov, L. D., Mihaylova-Todorova, S., Westfall, D. P., and Kennedy, C. (1999) Modulation of purinergic neurotransmission. Prog. Brain Res. 120, 11-20
52. Straub, V., and Campbell, K. P. (1997) Muscular dystrophies and the dystrophin-glycoprotein complex. Curr. Opin. Neurol. 10, 168-175
53. Betto, B., Senter, L., Ceoldo, S., Tarricone, E., Biral, D., and Salviati, G. (1999) Ecto-ATPase activity of α-sarcoglycan (adhalin). J. Biol. Chem. 274, 7907-7912
54. Sandona, D., Gastaldello, S., Martinello, T., and Betto, R. (2004) Characterization of the ATP-hydrolysing activity of alpha-sarcoglycan. Biochem. J. 381, 105-112
55. Ruegg, U. T., and Gillis, J. M. (1999) Calcium homeostasis in dystrophic muscle. Trends Pharmacol. Sci. 20, 351-352
56. 2+-activated K+ channels. Proc. Natl. Acad. Sci. USA 97, 4950-4955
57. Robert, V., Massimino, M. L., Tosello, V., Marsault, R., Cantini, M., Sorrentino, V., and Pozzan, T. (2001) Alteration in calcium handling at the subcellular level in mdx myotubes. J. Biol. Chem. 276, 4647-4651
58. Shivers, R. R., and Atkinson, B. G. (1984) The dystrophic murine skeletal muscle cell plasma membrane is structurally intact but "leaky" to creatine phosphokinase. A freeze-fracture analysis. Am. J. Pathol. 116, 482-496
59. Ferrari, D., Munerati, M., Melchiorri, L., Hanau, S., Di Virgilio, F., and Baricordi, O. R. (1994) Responses to extracellular ATP of lyphoblastoid cell lines from Duchenne muscular dystrophy patients. J. Am. Physiol 267, C886-C892
60. Noguchi, S., Wakabayashi, E., Imamura, M., Yoshida, M., and Ozawa, E. (1999) Developmental expression of sarcoglycan gene products in cultured myocytes. Biochem. Biophys. Res. Commun. 262, 88-93
61. Noguchi, S., Wakabayashi, E., Imamura, M., Yoshida, M., and Ozawa, E. (2000) Formation of sarcoglycan complex with differentiation in cultured myocytes. Eur. J. Biochem. 267, 640-648
62. Hentze, M. W., and Kulozik, A. E. (1999) A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96, 307-310
63. Munroe, S. H. (2004) Diversity of antisense regulation in eukaryotes: multiple mechanisms, emerging patterns. J. Cell. Biochem. 93, 664-671
64. 2+ handling and survival in mdx skeletal muscle cells. FEBS Lett. 439, 357-362